loading

Relmada Therapeutics Inc 주식(RLMD)의 최신 뉴스

pulisher
08:08 AM

Views of Wall Street’s Leading Experts on Relmada Therapeutics Inc - Setenews

08:08 AM
pulisher
Nov 22, 2025

Relmada Therapeutics, Inc.Common Stock (NQ: RLMD - Markets Financial Content

Nov 22, 2025
pulisher
Nov 21, 2025

Relmada Therapeutics Inc. (RLMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025
pulisher
Nov 21, 2025

Relmada Therapeutics, Inc. (RLMD) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Nov 21, 2025
pulisher
Nov 21, 2025

How risky is Relmada Therapeutics Inc. stock now2025 Key Lessons & Growth Focused Entry Reports - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How Relmada Therapeutics Inc. (4E2) stock trades in high volatilityEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

This Stock Is Up 704% in 2025 But Has No Products to Its Name - inkl

Nov 20, 2025
pulisher
Nov 20, 2025

Will Relmada Therapeutics Inc. stock sustain high P E ratiosCEO Change & Consistent Growth Equity Picks - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Relmada Therapeutics Inc. showing signs of accumulationQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Smart tools for monitoring Relmada Therapeutics Inc.’s price actionWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Mizuho Upgrades Relmada Therapeutics (RLMD) - Nasdaq

Nov 19, 2025
pulisher
Nov 19, 2025

Why Relmada Therapeutics Inc. (4E2) stock stays resilientShare Buyback & Reliable Intraday Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Relmada Therapeutics Inc. (4E2) stock outperform small cap peers - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What valuation ratios show for Relmada Therapeutics Inc. (4E2) stock - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Mizuho Upgrades RLMD to 'Outperform', Raises Price Target | RLMD Stock News - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

Relmada Therapeutics (RLMD) Receives Upgrade with Significant Up - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

Relmada Therapeutics upgraded by Mizuho with a new price target - Quantisnow

Nov 19, 2025
pulisher
Nov 19, 2025

Mizuho Upgrades Relmada Therapeutics to Outperform From Neutral - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Is Relmada Therapeutics Inc. stock ready for a breakoutOptions Play & Community Driven Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Mizuho upgrades Relmada Therapeutics stock to Outperform on NDV-01 potential - Investing.com India

Nov 19, 2025
pulisher
Nov 19, 2025

Mizuho Upgrades Relmada Therapeutics Inc (RLMD) to Outperform - StreetInsider

Nov 19, 2025
pulisher
Nov 18, 2025

Is Relmada Therapeutics Inc. building a consolidation base2025 Performance Recap & Detailed Earnings Play Strategies - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Will Relmada Therapeutics Inc. bounce back from current supportJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

What institutional flow reveals about Relmada Therapeutics Inc.Market Trend Summary & Stepwise Swing Trade Plans - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Is Relmada Therapeutics Inc 4E2 a good long term investmentMoving Average Crossovers & Free Get High Impact Recommendations - earlytimes.in

Nov 16, 2025
pulisher
Nov 16, 2025

Relmada Therapeutics Reports Q3 2025 Financial Results - MSN

Nov 16, 2025
pulisher
Nov 16, 2025

Will Relmada Therapeutics Inc. stock gain from lower inflationJuly 2025 Sector Moves & Real-Time Chart Pattern Alerts - newser.com

Nov 16, 2025
$39.54
price down icon 0.53%
$31.40
price up icon 1.88%
$105.55
price down icon 0.65%
$99.71
price up icon 3.28%
biotechnology ONC
$335.17
price up icon 0.74%
$209.02
price up icon 1.01%
자본화:     |  볼륨(24시간):